血清镁、HNF1β基因型与肾移植后糖尿病的前瞻性研究
该前瞻性研究在活体肾移植受者中于术后第一年预设时间点检测血清镁和他克莫司浓度,并探索HNF1β单核苷酸多态性(SNP)的作用。167例受者中29例(17%)在1年后发生移植后糖尿病(PTDM)。较低的血清镁是PTDM的独立危险因素;HNF1β SNP rs752010 G>A可能通过影响胰岛素分泌而非低镁血症增加PTDM风险,但需进一步确认。
要点
- 肾移植术后第一年较低的血清镁是移植后糖尿病(PTDM)的独立危险因素。
- 他克莫司浓度越高,血清镁越低,低镁血症风险越高。
- HNF1β SNP rs752010 G>A可能增加PTDM风险,但校正年龄和性别后失去显著性。
核心结论
- 肾移植术后第一年较低的血清镁是移植后糖尿病(PTDM)的独立危险因素。
- HNF1β SNP rs752010 G>A可能通过影响胰岛素分泌而非低镁血症增加PTDM风险,但其作用仍需进一步确认。
研究设计与样本
- 前瞻性研究,在活体肾移植受者术后第一年预设时间点测量血清镁和他克莫司浓度。
- 探索HNF1β单核苷酸多态性(SNP)的作用,因HNF1β调节胰岛素分泌和肾脏镁处理。
- 使用重复测量和回归分析分析与PTDM的关联。
主要发现
- 167例肾移植受者中29例(17%)在1年后发生PTDM。
- 较高的他克莫司浓度与较低的血清镁显著相关,并增加低镁血症风险。
- 发生PTDM的患者血清镁轨迹显著低于未发生PTDM的患者。
- 多变量分析中,较低的血清镁、年龄和体重指数是PTDM的独立危险因素。
- 在受者中,HNF1β SNP rs752010 G>A显著增加PTDM风险(OR=2.56,95%CI 1.05-6.23),但不增加低镁血症风险;校正年龄和性别后该关联失去显著性(OR=2.24,95%CI 0.90-5.57)。
临床怎么用
- 肾移植术后第一年监测血清镁可能有助于识别PTDM高风险患者。
- 管理他克莫司浓度时需关注其对血清镁和PTDM风险的影响。
局限性
- HNF1β SNP rs752010 G>A与PTDM的关联在校正年龄和性别后失去显著性,需进一步确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retrospective studies suggest that tacrolimus-induced hypomagnesaemia is a risk factor for post-transplant diabetes mellitus (PTDM), but prospective studies are lacking. METHODS: This was a prospective study with measurements of serum magnesium and tacrolimus at pre-specified time points in the first year after living donor kidney transplantation (KT). The role of single nucleotide polymorphisms (SNPs) in hepatocyte nuclear factor 1β (HNF1β) was also explored because HNF1β regulates insulin secretion and renal magnesium handling. Repeated measurement and regression analyses were used to analyse associations with PTDM. RESULTS: In our cohort, 29 out of 167 kidney transplant recipients developed PTDM after 1 year (17%). Higher tacrolimus concentrations were significantly associated with lower serum magnesium and increased risk of hypomagnesaemia. Patients who developed PTDM had a significantly lower serum magnesium trajectory than patients who did not develop PTDM. In multivariate analysis, lower serum magnesium, age and body mass index were independent risk factors for PTDM. In recipients, the HNF1β SNP rs752010 G > A significantly increased the risk of PTDM [odds ratio (OR) = 2.56, 95% confidence interval (CI) 1.05-6.23] but not of hypomagnesaemia. This association lost significance after correction for age and sex (OR = 2.24, 95% CI 0.90-5.57). No association between HNF1β SNPs and PTDM was found in corresponding donors. CONCLUSIONS: A lower serum magnesium in the first year after KT is an independent risk factor for PTDM. The HNF1β SNP rs752010 G > A may add to this risk through an effect on insulin secretion rather than hypomagnesaemia, but its role requires further confirmation.
引用
- van der Burgh AC, Moes A, Kieboom BCT, et al. Serum magnesium, hepatocyte nuclear factor 1β genotype and post-transplant diabetes mellitus: a prospective study. Nephrol Dial Transplant. 2020. PMID: 31361318. doi:10.1093/ndt/gfz145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。